| Prognostic impact and landscape of NOTCH1 mutations in chronic lymphocytic leukemia (CLL): a study on 852 patients S Weissmann, A Roller, S Jeromin, M Hernandez, M Abaigar, ... Leukemia 27 (12), 2393-2396, 2013 | 87 | 2013 |
| Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes MT Cedena, I Rapado, A Santos-Lozano, R Ayala, E Onecha, M Abaigar, ... Oncotarget 8 (63), 106948, 2017 | 51 | 2017 |
| Genome-wide DNA copy number analysis of acute lymphoblastic leukemia identifies new genetic markers associated with clinical outcome M Forero-Castro, C Robledo, R Benito, M Abaigar, A Africa Martin, M Arefi, ... PLoS One 11 (2), e0148972, 2016 | 50 | 2016 |
| Single nucleotide polymorphism array karyotyping: a diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing L Arenillas, M Mallo, F Ramos, K Guinta, E Barragan, E Lumbreras, ... Genes, Chromosomes and Cancer 52 (12), 1167-1177, 2013 | 47 | 2013 |
| Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia L Palomo, M Ibanez, M Abáigar, I Vazquez, S Alvarez, M Cabezon, ... British Journal of Haematology 188 (5), 605-622, 2020 | 44 | 2020 |
| Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia M Forero-Castro, C Robledo, R Benito, I Bodega-Mayor, I Rapado, ... British journal of cancer 117 (2), 256-265, 2017 | 41 | 2017 |
| Chromothripsis is a recurrent genomic abnormality in high-risk myelodysplastic syndromes M Abaigar, C Robledo, R Benito, F Ramos, M Diez-Campelo, L Hermosin, ... PLoS One 11 (10), e0164370, 2016 | 36 | 2016 |
| Deregulation of genes related to iron and mitochondrial metabolism in refractory anemia with ring sideroblasts M del Rey, R Benito, C Fontanillo, FJ Campos-Laborie, K Janusz, ... PLoS One 10 (5), e0126555, 2015 | 32 | 2015 |
| Prognostic impact of the number of methylated genes in myelodysplastic syndromes and acute myeloid leukemias treated with azacytidine M Abáigar, F Ramos, R Benito, M Díez-Campelo, J Sánchez-del-Real, ... Annals of hematology 92, 1543-1552, 2013 | 30 | 2013 |
| Application of FISH 7q in MDS patients without monosomy 7 or 7q deletion by conventional G-banding cytogenetics: Does− 7/7q− detection by FISH have prognostic value? V Ademà, JM Hernández, M Abáigar, E Lumbreras, E Such, A Calull, ... Leukemia research 37 (4), 416-421, 2013 | 27 | 2013 |
| CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase M Hernández-Sánchez, J Kotaskova, AE Rodríguez, L Radova, ... Leukemia 33 (2), 518-558, 2019 | 23 | 2019 |
| Co-occurrence of cohesin complex and Ras signaling mutations during progression from myelodysplastic syndromes to secondary acute myeloid leukemia M Martín-Izquierdo, M Abáigar, JM Hernández-Sánchez, D Tamborero, ... Haematologica 106 (8), 2215, 2021 | 18 | 2021 |
| Identification of expression patterns in the progression of disease stages by integration of transcriptomic data S Aibar, M Abaigar, FJ Campos-Laborie, JM Sánchez-Santos, ... BMC bioinformatics 17, 11-21, 2016 | 18 | 2016 |
| Imatinib therapy of chronic myeloid leukemia restores the expression levels of key genes for DNA damage and cell-cycle progression R Benito, E Lumbreras, M Abaigar, NC Gutierrez, M Delgado, C Robledo, ... Pharmacogenetics and genomics 22 (5), 381-388, 2012 | 16 | 2012 |
| Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low-and intermediate-risk MDS patients K Janusz, MM Izquierdo, FL Cadenas, F Ramos, JMH Sánchez, ... Annals of Hematology, 1-10, 2021 | 11 | 2021 |
| A two-step approach for sequencing spliceosome-related genes as a complementary diagnostic assay in MDS patients with ringed sideroblasts K Janusz, M Del Rey, M Abáigar, R Collado, D Ivars, ... Leukemia research 56, 82-87, 2017 | 6 | 2017 |
| aCGH-MAS: Analysis of aCGH by means of Multiagent System JF De Paz, R Benito, J Bajo, AE Rodríguez, M Abáigar BioMed research international 2015, 2015 | 6 | 2015 |
| NEMHESYS—European perspective on the implementation of next-generation sequencing into clinical diagnostics I Serramito-Gómez, KM Clarke, AE Rodríguez-Vicente, JE McGimpsey, ... HemaSphere 5 (3), e541, 2021 | 4 | 2021 |
| Genome-wide transcriptomics leads to the identification of deregulated genes after deferasirox therapy in low-risk MDS patients JMH Sánchez, E Lumbreras, M Díez-Campelo, T Gonzalez, DA Lopez, ... The Pharmacogenomics Journal 20 (5), 664-671, 2020 | 4 | 2020 |
| Chronic graft-versus-host disease could ameliorate the impact of adverse somatic mutations in patients with myelodysplastic syndromes and hematopoietic stem cell transplantation JC Caballero, M Sanchez Barba, JM Hernandez Sanchez, E Such, ... Annals of Hematology 98, 2151-2162, 2019 | 2 | 2019 |
